EDGAR Filing Documents for 0001628280-23-022224

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001628280-23-022224

Filing Date

2023-06-15

Accepted

2023-06-15 16:12:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	zentalis-finalregistereddi.htm	424B5	414699
2	EX-FILING FEES	exhibit107-prosupp.htm	EX-FILING FEES	29914
3		logoa.jpg	GRAPHIC	38416
4		zenalis_primarybluenavya.jpg	GRAPHIC	68307
	Complete submission text file	0001628280-23-022224.txt		585378

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018

Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791

Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255769 | Film No.: 231017465
SIC: 2834 Pharmaceutical Preparations